CN106317155B - 一种还原性葫芦烷型三萜及其制法和用途 - Google Patents
一种还原性葫芦烷型三萜及其制法和用途 Download PDFInfo
- Publication number
- CN106317155B CN106317155B CN201610701140.0A CN201610701140A CN106317155B CN 106317155 B CN106317155 B CN 106317155B CN 201610701140 A CN201610701140 A CN 201610701140A CN 106317155 B CN106317155 B CN 106317155B
- Authority
- CN
- China
- Prior art keywords
- methanol
- chloroform
- preparation
- compound
- volume ratio
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 10
- XBZYWSMVVKYHQN-MYPRUECHSA-N (4as,6as,6br,8ar,9r,10s,12ar,12br,14bs)-10-hydroxy-2,2,6a,6b,9,12a-hexamethyl-9-[(sulfooxy)methyl]-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-icosahydropicene-4a-carboxylic acid Chemical compound C1C[C@H](O)[C@@](C)(COS(O)(=O)=O)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C XBZYWSMVVKYHQN-MYPRUECHSA-N 0.000 title abstract description 4
- 150000001335 aliphatic alkanes Chemical class 0.000 title abstract description 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims abstract description 22
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims abstract description 20
- 150000001875 compounds Chemical class 0.000 claims abstract description 14
- 239000000843 powder Substances 0.000 claims abstract description 8
- 230000002401 inhibitory effect Effects 0.000 claims abstract description 4
- 239000000284 extract Substances 0.000 claims description 15
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 12
- 238000010828 elution Methods 0.000 claims description 11
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 9
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims description 9
- 235000019441 ethanol Nutrition 0.000 claims description 7
- GBMDVOWEEQVZKZ-UHFFFAOYSA-N methanol;hydrate Chemical compound O.OC GBMDVOWEEQVZKZ-UHFFFAOYSA-N 0.000 claims description 7
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 6
- WORJEOGGNQDSOE-UHFFFAOYSA-N chloroform;methanol Chemical compound OC.ClC(Cl)Cl WORJEOGGNQDSOE-UHFFFAOYSA-N 0.000 claims description 6
- 239000003480 eluent Substances 0.000 claims description 6
- 238000000605 extraction Methods 0.000 claims description 5
- 238000010438 heat treatment Methods 0.000 claims description 5
- 238000010992 reflux Methods 0.000 claims description 5
- 238000005227 gel permeation chromatography Methods 0.000 claims description 4
- 239000007791 liquid phase Substances 0.000 claims description 4
- 239000003208 petroleum Substances 0.000 claims description 4
- 238000000746 purification Methods 0.000 claims description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 4
- 238000010898 silica gel chromatography Methods 0.000 claims description 3
- 239000002904 solvent Substances 0.000 claims description 3
- 239000002246 antineoplastic agent Substances 0.000 claims description 2
- 229940041181 antineoplastic drug Drugs 0.000 claims description 2
- 238000002845 discoloration Methods 0.000 claims description 2
- 239000012467 final product Substances 0.000 claims description 2
- 239000006071 cream Substances 0.000 claims 1
- XYIBRDXRRQCHLP-UHFFFAOYSA-N ethyl acetoacetate Chemical group CCOC(=O)CC(C)=O XYIBRDXRRQCHLP-UHFFFAOYSA-N 0.000 claims 1
- 238000000926 separation method Methods 0.000 claims 1
- 235000007586 terpenes Nutrition 0.000 abstract description 16
- 210000004027 cell Anatomy 0.000 abstract description 8
- -1 cucurbitane terpenes Chemical class 0.000 abstract description 8
- 239000003814 drug Substances 0.000 abstract description 5
- 238000004458 analytical method Methods 0.000 abstract description 4
- 239000000126 substance Substances 0.000 abstract description 4
- 206010028980 Neoplasm Diseases 0.000 abstract description 3
- 230000002265 prevention Effects 0.000 abstract description 3
- 239000002994 raw material Substances 0.000 abstract description 2
- 210000004881 tumor cell Anatomy 0.000 abstract description 2
- 150000003505 terpenes Chemical class 0.000 description 9
- AOJJSUZBOXZQNB-TZSSRYMLSA-N Doxorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 AOJJSUZBOXZQNB-TZSSRYMLSA-N 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- 238000005481 NMR spectroscopy Methods 0.000 description 3
- 230000000259 anti-tumor effect Effects 0.000 description 3
- ZYZJWAJOTPNVPI-ZVBSCDOUSA-N cucurbitane Chemical compound C([C@H]1[C@]2(C)CC[C@@H]([C@]2(CC[C@]11C)C)[C@H](C)CCCC(C)C)CC2[C@H]1CCCC2(C)C ZYZJWAJOTPNVPI-ZVBSCDOUSA-N 0.000 description 3
- 150000003648 triterpenes Chemical class 0.000 description 3
- 238000005160 1H NMR spectroscopy Methods 0.000 description 2
- 238000001460 carbon-13 nuclear magnetic resonance spectrum Methods 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- 229960004679 doxorubicin Drugs 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000002024 ethyl acetate extract Substances 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 230000003285 pharmacodynamic effect Effects 0.000 description 2
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 2
- 229930182490 saponin Natural products 0.000 description 2
- 150000007949 saponins Chemical class 0.000 description 2
- INLFWQCRAJUDCR-IQVMEADQSA-N (1R,2S,4S,5'S,6R,7S,8R,9S,12S,13S)-5',7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icosane-6,2'-oxane] Chemical compound O([C@@H]1[C@@H]([C@]2(CC[C@@H]3[C@@]4(C)CCCCC4CC[C@H]3[C@@H]2C1)C)[C@@H]1C)[C@]11CC[C@H](C)CO1 INLFWQCRAJUDCR-IQVMEADQSA-N 0.000 description 1
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 1
- 208000004429 Bacillary Dysentery Diseases 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 241000220485 Fabaceae Species 0.000 description 1
- 206010017915 Gastroenteritis shigella Diseases 0.000 description 1
- 241000906682 Hemsleya Species 0.000 description 1
- 241000466342 Hemsleya pengxianensis Species 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 241001529246 Platymiscium Species 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 241000934136 Verruca Species 0.000 description 1
- 208000000260 Warts Diseases 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 208000019065 cervical carcinoma Diseases 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 238000004737 colorimetric analysis Methods 0.000 description 1
- 229940125904 compound 1 Drugs 0.000 description 1
- 238000000205 computational method Methods 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 125000001033 ether group Chemical group 0.000 description 1
- 125000004494 ethyl ester group Chemical group 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 230000010355 oscillation Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 1
- JUJWROOIHBZHMG-RALIUCGRSA-N pyridine-d5 Chemical compound [2H]C1=NC([2H])=C([2H])C([2H])=C1[2H] JUJWROOIHBZHMG-RALIUCGRSA-N 0.000 description 1
- 201000005113 shigellosis Diseases 0.000 description 1
- 201000010153 skin papilloma Diseases 0.000 description 1
- 238000010183 spectrum analysis Methods 0.000 description 1
- 206010041823 squamous cell carcinoma Diseases 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
组别 | HeLa细胞 | KB细胞 |
实验组 | 10.4 ± 3.2 | 44.1± 2.7 |
对照组 | 1.3 ± 0.11 | 0.89 ± 0.03 |
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610701140.0A CN106317155B (zh) | 2016-08-23 | 2016-08-23 | 一种还原性葫芦烷型三萜及其制法和用途 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610701140.0A CN106317155B (zh) | 2016-08-23 | 2016-08-23 | 一种还原性葫芦烷型三萜及其制法和用途 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN106317155A CN106317155A (zh) | 2017-01-11 |
CN106317155B true CN106317155B (zh) | 2018-11-02 |
Family
ID=57742637
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610701140.0A Active CN106317155B (zh) | 2016-08-23 | 2016-08-23 | 一种还原性葫芦烷型三萜及其制法和用途 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106317155B (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114133422B (zh) * | 2021-12-16 | 2022-12-20 | 中国医学科学院药用植物研究所 | 一种葫芦烷三萜类化合物及其制备方法和应用 |
CN115141245B (zh) * | 2022-08-03 | 2024-02-23 | 河南中医药大学 | 从中华雪胆中提取的具有抗乳腺炎活性的葫芦烷型四环三萜类化合物及其制备方法与应用 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105832748A (zh) * | 2016-05-06 | 2016-08-10 | 深圳以诺生物制药有限公司 | 一种从罗汉果总皂苷中制备罗汉果醇新型衍生物的方法 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005040189A1 (en) * | 2003-10-27 | 2005-05-06 | Panagin Pharmaceuticals Inc. | Novel dammarane sapogenins and their use as anti-cancer agents |
-
2016
- 2016-08-23 CN CN201610701140.0A patent/CN106317155B/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105832748A (zh) * | 2016-05-06 | 2016-08-10 | 深圳以诺生物制药有限公司 | 一种从罗汉果总皂苷中制备罗汉果醇新型衍生物的方法 |
Non-Patent Citations (1)
Title |
---|
Potential AMPK activators of cucurbitane triterpenoids fromSiraitia grosvenorii Swingle;Xu-bing Chen et al.;《Bioorganic & Medicinal Chemistry》;20110822;第19卷;第5776–5781页 * |
Also Published As
Publication number | Publication date |
---|---|
CN106317155A (zh) | 2017-01-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102058678B (zh) | 一种治疗脂肪肝的药物或保健食品组合物 | |
CN102940687B (zh) | 一种川楝子提取物及其用途 | |
CN104817432B (zh) | 一种二萜类化合物的抗肿瘤用途 | |
CN106317156B (zh) | 一种五羟基二酮类葫芦烷型三萜及其制法和用途 | |
CN106317155B (zh) | 一种还原性葫芦烷型三萜及其制法和用途 | |
CN104873570B (zh) | 一种夏枯草总黄酮的提取纯化方法及其应用 | |
CN104628531B (zh) | 一种从山橿中提取的化合物sj-11及其制备方法与应用 | |
CN106397530B (zh) | 一种缩合环类葫芦烷型三萜及其制法和用途 | |
CN106317157B (zh) | 一种多羟基双酮类葫芦烷型三萜及其制法和用途 | |
CN103610762B (zh) | 一种塞北紫堇总生物碱提取物及其提取方法 | |
CN106045819B (zh) | 一种云实三环二萜及其制法和用途 | |
CN104892714B (zh) | 一种新的灵芝三萜及其制备方法和医药用途 | |
CN106380503B (zh) | 一种三羟基单酮类葫芦烷型三萜及其制法和用途 | |
CN106674086B (zh) | 一种哌啶酮类生物碱化合物及其制备方法和应用 | |
CN105418722B (zh) | 一种名为油茶皂苷c4和c5的五环三萜类化合物的制备方法 | |
CN106397523B (zh) | 一种甲基羟基化葫芦烷型三萜及其制法和用途 | |
CN108836982A (zh) | 一种蟾皮有效部位及其制备方法 | |
CN103833818B (zh) | 一种油茶皂苷化合物、其制备方法、应用及其制备的抗肿瘤药物 | |
CN103623066B (zh) | 一种用于制备抗癌药物的塞北紫堇总生物碱提取物及其应用 | |
CN106045951B (zh) | 一种云实内酯及其制法和用途 | |
CN104788291A (zh) | 闹羊花分离的二萜类化合物的抗肿瘤药物及方法用途 | |
CN104529968B (zh) | 一种抗肿瘤二萜类化合物,其药物组合物及其制备方法和用途 | |
CN116554254B (zh) | 一种具有镇静及缓解失眠作用的化合物及其应用 | |
CN109206392A (zh) | 一种香豆素类化合物及其制备方法与应用 | |
CN103169713B (zh) | 一种甾醇类衍生物在制备抗癌药物中的用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20201105 Address after: No. 287, Minhe street, Anyang Town, Du'an Yao Autonomous County, Hechi City, Guangxi Zhuang Autonomous Region Patentee after: Du'an Yao Autonomous County metrological verification and Testing Institute Address before: 416000 Hunan, Xiangxi Tujia and Miao Autonomous Prefecture, Jishou City People's road, No. 120 Patentee before: JISHOU University |
|
TR01 | Transfer of patent right | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20170111 Assignee: Hechi Food and Drug Inspection Institute Assignor: Du'an Yao Autonomous County metrological verification and Testing Institute Contract record no.: X2023980047639 Denomination of invention: A Reducing Cucurbitane Triterpene and Its Preparation and Application Granted publication date: 20181102 License type: Common License Record date: 20231122 |
|
EE01 | Entry into force of recordation of patent licensing contract |